Topic: DaVita Inc.
(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.The biotechnology company said in a regulatory filing on ...
(Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market for its flagship drug Epogen.Amgen said in a ...